Scarica l'app Stockscreener
79.62
2.93%
-2.40
Dopo l'orario di chiusura:
79.62
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$82.02
Aprire:
$81.78
Volume 24 ore:
3.14M
Relative Volume:
0.80
Capitalizzazione di mercato:
$38.71B
Reddito:
$6.13B
Utile/perdita netta:
$272.21M
Rapporto P/E:
144.21
EPS:
0.5521
Flusso di cassa netto:
$1.38B
1 W Prestazione:
-2.56%
1M Prestazione:
-8.76%
6M Prestazione:
-1.70%
1 anno Prestazione:
+25.11%
Intervallo 1D:
$78.85
$82.10
Intervallo di 1 settimana:
$78.08
$82.95
Portata 52W:
$61.76
$91.06
Ventas Inc Stock (VTR) Company Profile
Nome
Ventas Inc
Settore
Industria
Telefono
(312) 660-3800
Indirizzo
300 N LASALLE STREET, CHICAGO, IL
Compare VTR vs WELL, DOC, OHI, AHR
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
VTR
Ventas Inc
|
79.62 | 39.88B | 6.13B | 272.21M | 1.38B | 0.5521 |
WELL
Welltower Inc
|
200.00 | 146.07B | 11.75B | 1.46B | 2.19B | -0.6014 |
DOC
Healthpeak Properties Inc
|
19.77 | 13.64B | 2.87B | 250.10M | 1.13B | 0.3188 |
OHI
Omega Healthcare Investors Inc
|
43.80 | 13.24B | 1.24B | 655.98M | 857.80M | 2.063 |
AHR
American Healthcare Reit Inc
|
45.70 | 9.82B | 2.27B | 70.82M | 165.88M | 0.4079 |
Ventas Inc Stock (VTR) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-01-09 | Iniziato | Goldman | Buy |
| 2025-10-01 | Iniziato | Cantor Fitzgerald | Overweight |
| 2025-09-19 | Iniziato | UBS | Neutral |
| 2025-06-23 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2025-03-07 | Aggiornamento | Argus | Hold → Buy |
| 2025-01-17 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2024-10-01 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2024-03-18 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2024-02-26 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2024-01-30 | Iniziato | Deutsche Bank | Buy |
| 2024-01-16 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2023-11-07 | Aggiornamento | Wedbush | Neutral → Outperform |
| 2023-10-11 | Iniziato | Exane BNP Paribas | Outperform |
| 2023-10-03 | Iniziato | Wedbush | Neutral |
| 2023-09-20 | Downgrade | Raymond James | Strong Buy → Outperform |
| 2023-08-11 | Downgrade | BofA Securities | Buy → Neutral |
| 2023-06-23 | Aggiornamento | Raymond James | Outperform → Strong Buy |
| 2023-04-20 | Iniziato | Wells Fargo | Overweight |
| 2022-11-01 | Reiterato | Credit Suisse | Outperform |
| 2022-11-01 | Downgrade | Raymond James | Strong Buy → Outperform |
| 2022-10-10 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2022-06-30 | Aggiornamento | Jefferies | Hold → Buy |
| 2022-06-23 | Iniziato | Credit Suisse | Outperform |
| 2022-06-03 | Iniziato | CapitalOne | Overweight |
| 2022-05-18 | Aggiornamento | Credit Suisse | Neutral → Outperform |
| 2022-03-11 | Aggiornamento | BMO Capital Markets | Market Perform → Outperform |
| 2022-03-11 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2022-02-01 | Iniziato | Credit Suisse | Neutral |
| 2022-01-20 | Aggiornamento | Mizuho | Neutral → Buy |
| 2021-12-14 | Aggiornamento | Citigroup | Neutral → Buy |
| 2021-11-22 | Downgrade | SMBC Nikko | Outperform → Neutral |
| 2021-10-04 | Ripresa | Morgan Stanley | Equal-Weight |
| 2021-09-23 | Aggiornamento | Raymond James | Outperform → Strong Buy |
| 2021-09-07 | Aggiornamento | Deutsche Bank | Hold → Buy |
| 2021-08-26 | Aggiornamento | BMO Capital Markets | Underperform → Market Perform |
| 2021-07-14 | Ripresa | Mizuho | Neutral |
| 2021-06-15 | Iniziato | Wolfe Research | Outperform |
| 2021-06-11 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2021-05-13 | Aggiornamento | KeyBanc Capital Markets | Underweight → Overweight |
| 2021-05-13 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2021-01-08 | Downgrade | BMO Capital Markets | Market Perform → Underperform |
| 2021-01-06 | Iniziato | Robert W. Baird | Neutral |
| 2020-11-30 | Aggiornamento | BofA Securities | Underperform → Buy |
| 2020-11-10 | Aggiornamento | Jefferies | Underperform → Hold |
| 2020-09-08 | Downgrade | Argus | Buy → Hold |
| 2020-09-02 | Ripresa | Stifel | Hold |
| 2020-08-20 | Downgrade | Raymond James | Strong Buy → Outperform |
| 2020-08-14 | Aggiornamento | Evercore ISI | Underperform → In-line |
| 2020-08-14 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
| 2020-06-15 | Downgrade | Evercore ISI | In-line → Underperform |
| 2020-03-25 | Aggiornamento | Raymond James | Mkt Perform → Strong Buy |
| 2020-03-23 | Downgrade | BofA/Merrill | Neutral → Underperform |
| 2020-03-10 | Downgrade | Jefferies | Buy → Underperform |
| 2020-02-28 | Aggiornamento | Raymond James | Underperform → Mkt Perform |
| 2020-01-22 | Downgrade | Raymond James | Mkt Perform → Underperform |
| 2020-01-17 | Aggiornamento | Jefferies | Hold → Buy |
| 2019-12-20 | Ripresa | Mizuho | Neutral |
| 2019-12-10 | Downgrade | Wells Fargo | Market Perform → Underperform |
| 2019-11-19 | Aggiornamento | Argus | Hold → Buy |
| 2019-10-30 | Downgrade | Stifel | Buy → Hold |
| 2019-10-28 | Downgrade | CapitalOne | Overweight → Equal Weight |
| 2019-10-28 | Downgrade | Citigroup | Buy → Neutral |
Mostra tutto
Ventas Inc Borsa (VTR) Ultime notizie
How Investors Are Reacting To Ventas (VTR) Reaffirming Its Dividend And Senior Housing Outlook - simplywall.st
A Look At Ventas (VTR) Valuation After Updated Outlook And Dividend Reaffirmation - Yahoo Finance
Ventas Inc stock (US9227931050): Healthcare REIT focuses on senior housing recovery and capital recy - AD HOC NEWS
(VTR) Volatility Zones as Tactical Triggers - Stock Traders Daily
Ventas Inc. Stock Draws Aggressive Price Target Hikes - timothysykes.com
Ventas expects $3.86 FFO per share in 2026 as it raises investment plan to $3B - MSN
Ventas Stock Climbs As Analysts Hike Price Targets And Guidance Holds - timothysykes.com
Insider Buying: Michael Embler Acquires Shares of Ventas Inc (VT - GuruFocus
Ventas jumps as investors digest upbeat senior-housing update and 2026 outlook - Quiver Quantitative
Ventas director Michael Embler acquires $197,025 in company stock By Investing.com - Investing.com India
Ventas Inc. stock outperforms competitors on strong trading day - MarketWatch
Ventas director Michael Embler acquires $197,025 in company stock - Investing.com
Ventas (VTR) director adds 2,500 shares in open-market purchase - Stock Titan
Daiwa Securities Group Inc. Has $364.12 Million Stake in Ventas, Inc. $VTR - MarketBeat
Cibc World Market Inc. Has $25.69 Million Holdings in Ventas, Inc. $VTR - MarketBeat
Top Ventas (VTR) Competitors 2026 - MarketBeat
Goldman Sachs Maintains Ventas Inc(VTR.US) With Buy Rating, Maintains Target Price $110 - Moomoo
REITs' fundamentals bode well for earnings outlook amid geopolitical uncertainty (DLR:NYSE) - Seeking Alpha
Ventas Stock Plummets 11% With 6-Day Losing Streak - Trefis
Ventas Stock 6-Day Losing Spree: Stock Falls -11% - Trefis
AVIP Intech U.S. Low Volatility Portfolio's Ventas Inc(VTR) Holding History - GuruFocus
Ventas Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Ventas Chairman and CEO Debra A. Cafaro to Receive Cyrus McCormick Making History Award for Historic Corporate Achievement - New Castle News
What's in the offing for Ventas stock this earnings season? - MSN
Morgan Stanley Maintains Ventas Inc(VTR.US) With Hold Rating, Maintains Target Price $90 - 富途牛牛
Ventas Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Hazelview Securities Inc.'s Ventas Inc(VTR) Holding History - GuruFocus
Ventas VTR Q1 2026 Earnings Call Transcript - AOL.com
Norges Bank Buys Shares of 6,132,989 Ventas, Inc. $VTR - MarketBeat
Cbre Investment Management Listed Real Assets LLC Grows Stock Holdings in Ventas, Inc. $VTR - MarketBeat
Forsta AP Fonden Decreases Holdings in Ventas, Inc. $VTR - MarketBeat
Ventas Inc (VTR) Shares Fall 3.2% -- GF Value Says Still Overval - GuruFocus
VTR Maintained by Wells Fargo -- Price Target Raised to $96 - GuruFocus
Ventas Affirms Full-Year 2026 FFO Guidance - marketscreener.com
VTR: Senior housing growth accelerates, with raised 2026 guidance and strong financial performance - TradingView
(VTR) Ventas Reaffirms 2026 Normalized FFO Per Share Outlook of $3.82$3.89 - marketscreener.com
Ventas Inc. stock outperforms competitors despite losses on the day - MarketWatch
Ventas Inc. stock (US92276F1003): shares steady after latest market update - AD HOC NEWS
Ventas Issues Business Update and Will Participate in Investor Meetings at Nareit’s REITweek 2026 Investor Conference - The Joplin Globe
Why Is Healthcare Real Estate Demand Keeping Ventas in Focus? - Kalkine Media
Ventas (NYSE:VTR) Stock Price Expected to Rise, Wells Fargo & Company Analyst Says - MarketBeat
Ventas Inc stock (US9182041080): shares steady as U.S. healthcare REIT tracks sector moves - AD HOC NEWS
Ventas, Inc. $VTR Shares Sold by Lasalle Investment Management Securities LLC - MarketBeat
Wells Fargo Adjusts Price Target on Ventas to $96 From $93, Maintains Overweight Rating - marketscreener.com
Thames Capital Management LLC Makes New $4.78 Million Investment in Ventas, Inc. $VTR - MarketBeat
National Pension Service Purchases 91,389 Shares of Ventas, Inc. $VTR - MarketBeat
Geode Capital Management LLC Has $1 Billion Position in Ventas, Inc. $VTR - MarketBeat
Welltower And Ventas Share The Same Demand Story, But Their Dividend Structures Do NotVentas (NYSE:VTR - Benzinga
Ventas is buying The Bristal Assisted Living facility in Westbury, plans $1.2M in upgrades - Newsday
Ventas Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Ventas Named a Founding Partner of Real Estate Executive Council’s Diversity Initiative - Nareit
Ventas Inc Azioni (VTR) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.10%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):